Neurizon Files IND Application to Support HEALEY ALS Platform Trial ...Middle East

News by : (PR Newswire) -

Highlights: IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001 The IND is a comprehensive dossier of information, including animal and human studies, pharmacokinetic analyses, toxicology studies,...

Read More Details
Finally We wish PressBee provided you with enough information of ( Neurizon Files IND Application to Support HEALEY ALS Platform Trial )

Also on site :

Most Viewed News
جديد الاخبار